Benzinga - Gainers
- PaxMedica, Inc. (NASDAQ: PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital.
- Secoo Holding Limited (NASDAQ: SECO) shares rose 29.6% to $0.35 in pre-market trading after dropping 7% on Thursday.
- IVERIC bio, Inc. (NASDAQ: ISEE) rose 20.9% to $20.84 in pre-market trading. Iveric Bio said that the FDA has granted breakthrough therapy designation for Avacincaptad Pegol for geographic atrophy.
- StoneCo Ltd. (NASDAQ: STNE) rose 20% to $11.84 in pre-market trading after the company reported Q3 results.
- Ross Stores (NASDAQ:ROST), Inc. (NASDAQ: ROST) rose 16.6% to $114.20 in pre-market trading after the company reported better-than-expected Q3 results and issued strong earnings guidance.
- Quhuo Limited (NASDAQ: QH) rose 15.6% to $1.92 in pre-market trading. Quhuo recently reported better-than-expected H1 results.
- Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 11.3% to $0.2710 in pre-market trading after dropping 5% on Thursday.
- Golden Sun Education Group Limited (NASDAQ: GSUN) rose 9.5% to $2.53 in pre-market trading after dropping 46% on Thursday.
- Provention Bio, Inc. (NASDAQ: PRVB) rose 9.1% to $8.99 in pre-market trading. Provention said on Thursday the U.S. Food and Drug Administration has given its nod for the use of TZIELD (teplizumab-mzwb) in those aged eight years and older — the first treatment targeted at delaying the onset of insulin-dependent type 1 diabetes.
- Palo Alto (NASDAQ:PANW) Networks, Inc. (NASDAQ: PANW) rose 8.6% to $170.00 in pre-market trading after the company reported better-than-expected results for its second quarter and issued strong FY23 earnings guidance. The company also announced plans to acquire Cider Security for approximately $195 million.
- Biora Therapeutics, Inc. (NASDAQ: BIOR) rose 7.4% to $0.2470 in pre-market trading after dropping 8% on Thursday. Biora Therapeutics recently posted a Q3 loss of $0.08 per share.
- The Gap, Inc. (NYSE: GPS) rose 7.2% to $13.63 in pre-market trading after the company reported better-than-expected Q3 sales results.
- AppHarvest, Inc. (NASDAQ: APPH) rose 7.1% to $1.36 in pre-market trading. AppHarvest recently reported worse-than-expected Q3 sales results.
- Virax Biolabs Group Limited (NASDAQ: VRAX) rose 5.7% to $1.49 in pre-market trading. Virax Biolabs recently named Richard Pallin as Vice President of In Vitro Diagnostic Sales.
- Applied Materials (NASDAQ:AMAT), Inc. (NASDAQ: AMAT) rose 3.8% to $108.37 in pre-market trading following upbeat quarterly results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Don’t forget to check out our premarket coverage here .
Losers
- Scilex Holding Company (NASDAQ: SCLX) shares fell 28% to $6.72 in pre-market trading after gaining over 6% on Thursday.
- G1 Therapeutics, Inc. (NASDAQ: GTHX) fell 24.4% to $6.46 in pre-market trading after the company reported pricing of $50.05 million public offering of 7.7 million shares of common stock at a price of $6.50 per share.
- BIMI International Medical, Inc. (NASDAQ: BIMI) shares fell 17.2% to $0.21 in pre-market trading.
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares fell 12.1% to $0.6202 in pre-market trading.
- Farfetch Limited (NYSE: FTCH) fell 11.3% to $8.11 in pre-market trading after the company reported worse-than-expected Q3 revenues. Gross merchandise value decreased 4.9% year over year.
- Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) fell 10.3% to $2.34 in pre-market trading after dropping 12% on Thursday.
- Cuentas Inc. (NASDAQ: CUEN) fell 9.1% to $0.2910 in pre-market trading after jumping 28% on Thursday.
- Smart for Life, Inc. (NASDAQ: SMFL) shares fell 9.1% to $0.40 in pre-market trading. Smart for Life recently posted Q3 sales of $5.40 million.
- The Very Good Food Company Inc. (NASDAQ: VGFC) fell 8.1% to $0.0715 in pre-market trading after gaining over 6% on Thursday.
- Ensysce Biosciences, Inc. (NASDAQ: ENSC) fell 6.7% to $2.37 in pre-market trading after dropping 9% on Thursday.
- Zhihu Inc. (NYSE: ZH) fell 6.6% to $1.27 in pre-market trading. Zhihu is expected to report Q3 financial results on November 30, 2022.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.